Compare News Corporation Class A Common Stock (NWSA) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
News Corporation Class A Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? News Corporation Class A Common Stock trades at $29.84 (market cap $16.49B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: News Corporation Class A Common Stock is the larger of the two by market cap, and News Corporation Class A Common Stock pays the higher dividend (0.67%). Which is the better fit depends on your goals — on Pluang, investors hold News Corporation Class A Common Stock for 6 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| NWSA | RDY | |
|---|---|---|
Market Cap | $16.49B | $10.61B |
Volume | 2,643,378 | 3,738,869 |
Sector | Media | Health |
52-Week High | $31.19 | $15.38 |
52-Week Low | $22.40 | $11.38 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $17.31B | $10.51B |
Dividend Yield | 0.67% | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
News Corporation (NWSA) trades at $29.63, up 0.85% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $32.20. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS of $0.35 surpassing the $0.21 expectation. Revenue for 2025 reached $8.45 billion, though net income is projected to decline significantly in 2026. Recent news highlights include the launch of a personalized news AI, 'Hamilton,' and ongoing speculation about a potential re-merger with Fox Corp.
The outlook is cautiously optimistic, supported by strong analyst sentiment and consistent earnings beats. Key opportunities lie in digital real estate and news monetization, while risks include a projected profit margin contraction and broader market volatility. The stock's current valuation, with a P/E of 28.77, suggests growth expectations are already priced in, requiring sustained execution to justify further upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About News Corporation Class A Common Stock
News Corporation operates businesses in news and information services, digital real estate, and book publishing. Its brands include Dow Jones, The Wall Street Journal, HarperCollins, Realtor.com, and realestate.com.au.
Read more on NWSA →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
